Free Trial

Aytu BioPharma (AYTU) SEC Filings & 10K Form

Aytu BioPharma logo
$1.60 0.00 (0.00%)
(As of 11/19/2024 ET)

Recent Aytu BioPharma SEC Filings

DateFilerForm TypeView
11/13/2024
4:36 PM
Aytu BioPharma (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G/A
11/13/2024
4:20 PM
Aytu BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
3:05 PM
Aytu BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:08 PM
Aytu BioPharma (Issuer)
Selhorn Ryan J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/08/2024
7:44 PM
Aytu BioPharma (Issuer)
DOCKERY CARL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
7:27 PM
Aytu BioPharma (Issuer)
JAIN ABHINAV (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
7:34 PM
Aytu BioPharma (Issuer)
Donofrio John Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
6:49 PM
Aytu BioPharma (Issuer)
Disbrow Jarrett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
6:55 PM
Aytu BioPharma (Issuer)
Disbrow Joshua R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
6:32 PM
Aytu BioPharma (Issuer)
LIU VIVIAN H (Reporting)
Form 4/A
11/08/2024
6:37 PM
Aytu BioPharma (Issuer)
LIU VIVIAN H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
6:23 PM
Aytu BioPharma (Issuer)
PYSZCZYMUKA GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
11:15 PM
Aytu BioPharma (Filer)
Form EFFECT
10/11/2024
4:01 PM
Aytu BioPharma (Filer)
Form S-3/A
10/02/2024
4:18 PM
Aytu BioPharma (Issuer)
PYSZCZYMUKA GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
7:00 AM
Aytu BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
3:29 PM
Aytu BioPharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/26/2024
3:32 PM
Aytu BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
7:00 AM
Aytu BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
4:20 PM
Aytu BioPharma (Issuer)
PYSZCZYMUKA GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
3:36 PM
Aytu BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2024
4:09 PM
Aytu BioPharma (Issuer)
Harkey Wilmot B. (Reporting)
Mack Daniel (Reporting)
Nantahala Capital Management, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:30 PM
Aytu BioPharma (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SC 13D/A
06/18/2024
7:05 AM
Aytu BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
3:44 PM
Aytu BioPharma (Issuer)
PYSZCZYMUKA GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:37 PM
Aytu BioPharma (Issuer)
PYSZCZYMUKA GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AYTU) was last updated on 11/19/2024 by MarketBeat.com Staff
From Our Partners